Announcement

Collapse
No announcement yet.

COVID- 19 Vaccine Dangers, Side Effects, Controversy - Closed thread, please see scientific library

Collapse
This topic is closed.
X
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Click image for larger version  Name:	Screen Shot 2022-02-10 at 16.55.26 (1).jpg Views:	1 Size:	90.9 KB ID:	938876
    This is a very strange and developing story I have been following since it first appeared on Dr. Jane Ruby's show. She recently broke the shocking story of an embalmer who along with others, discovered long, white fibrous stringy and stretchy clots of unknown composition.

    These white clots have been observed in the deceased, and according the the undertaker, never prior to the vaccine rollout. They have to remove them in order to infuse the body with embalming fluid, which is how they were first discovered. He says people who have them, appear to have died suddenly. The clots are typically found in the veins though there are some arterial as well. Nothing more is known other than people who are preparing bodies for rest are finding these strange fibrous white clots in the majority of the vaccinated deceased. More data is needed.

    At the present time, samples are being studied and the findings of the chemical analysis will be soon be known.
    Here is a screen shot from the video which is about 25 minutes long.

    At this juncture, I would like to believe this is a grand fiction. But I think it's important to listen to what people on the ground in the mortuaries are discovering alongside other whistleblowers, particularly if it is a new observation. Hopefully, it will turn out to be unrelated to the vaccines. Have a listen and decide for yourself if this is a story worth following.

    The second part of the video discusses the discoveries of the nanoparticles found in the vaccines, transhumanism, and an interview with Dr. David Martin.

    Comment


  • This is bizzare and horrifying. Right before the fall, she joked that Jesus must especially love her because she's done so well with her vaccines and COVID. She had bleeding on the brain - just sickening to hear her head crack on the stage. Poor woman said she meant no criticism of people who don't get vaccines. She was just trying to reassure her audience. She said that in the entertainment industry, you can't work without vaccines.

    https://www.thegatewaypundit.com/202...g-skull-video/
    Comedian Heather McDonald Says She Won’t Get 4th Covid Jab After Collapsing on Stage, Fracturing Skull (VIDEO)

    By Cristina Laila
    Published February 14, 2022 at 7:17pm
    Comedian Heather McDonald recently collapsed on stage and fractured her skull during her show in Tempe, Arizona seconds after delivering a joke about being triple vaxxed...
    ...
    Dr. Drew said he has a friend who still can’t walk after getting the Covid booster, but encouraged people to get jabbed anyway.



    Here's the story on Bob Saget - another tripled vaxxed entertainer. Injuries were worse. (Heather had black eyes from the skull trauma but not socket fractures. Sounds like Saget got up and fell again. At least Dr. Drew thought the risk for POTS is low 3 weeks after a shot for most people.

    The conspiracy theories about Bob Saget’s death seem to be thriving in the wake of an autopsy report that experts said could leave people wondering ‘if there is more to the story.&#8217…
    _____________________________________________

    Ask Congress to Investigate COVID Origins and Government Response to Pandemic.

    i love myself. the quietest. simplest. most powerful. revolution ever. ---- nayyirah waheed

    "...there’s an obvious contest that’s happening between different sectors of the colonial ruling class in this country. And they would, if they could, lump us into their beef, their struggle." ---- Omali Yeshitela, African People’s Socialist Party

    (My posts are not intended as advice or professional assessments of any kind.)
    Never forget Excalibur.

    Comment


    • GardenSpider
      GardenSpider commented
      Editing a comment
      Great post. I like what he says at the end.
      "Why am I going to take this shot blindly? Having blind faith... Ask questions. It's your body. You only get one body, one chance at life. Don't ruin it."

  • Autopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose


    ABSTRACT

    Context.– Myocarditis in adolescents has been diagnosed clinically following the administration of the second dose of an mRNA vaccine for coronavirus disease 2019 (COVID-19).

    Objective.– To examine the autopsy microscopic cardiac findings in adolescent deaths that occurred shortly following administration of the second Pfizer-BioNTech COVID-19 dose to determine if the “myocarditis” described in these instances has the typical histopathology of myocarditis.

    Design.– Clinical and autopsy investigation of two teenage boys who died shortly following administration of the second Pfizer-BioNTech COVID-19 dose.

    Results.– The microscopic examination revealed features resembling a catecholamine-induced injury, not typical myocarditis pathology.

    Conclusions.– The myocardial injury seen in these post-vaccine hearts is different from typical myocarditis and has an appearance most closely resembling a catecholamine-mediated stress (toxic) cardiomyopathy. Understanding that these instances are different from typical myocarditis and that cytokine storm has a known feedback loop with catecholamines may help guide screening and therapy.

    Comment


    • Matt Le Tissier - On the Record | Oracle Films
      https://rumble.com/vtsp9u-matt-le-ti...cle-films.html

      Why Aren’t We Investigating Surge in Sudden Deaths of Athletes?
      https://childrenshealthdefense.org/d...aths-athletes/
      • UK football legend and sports commentator, Matt Le Tissier, has been speaking out about the large number of athletes who have collapsed or died on the field, and has lost his job as a result.
      • Le Tissier says he has never seen anything like it in the 17 years he played football — he is calling for an investigation into the events and says ignoring it is a “massive dereliction of duty” by the officials.
      • Fact checkers and government officials are trying to negate or discredit information that supports the theory that mRNA injections are behind the sudden onslaught of injury and death, and they are studiously ignoring investigating the allegations.
      • The Vaccine Adverse Events Reporting System (VAERS) reflects injuries to athletes in the general population, but it’s possible that the reports are nowhere near current.

      Comment


      • Translation Google



        "Alarm signal"

        Vaccination consequences: BKK health insurance company writes a letter to the Paul Ehrlich Institute

        The health insurance company BKK has evaluated millions of insured data. The number of cases given by the Paul Ehrlich Institute for the consequences of vaccination are therefore too low.

        updated
        P. Debionne, 24.2.2022
        updated 02/24/2022 - 00:27

        A large German health insurance company has recorded figures on the side effects of Covid vaccines. The result was "a significant alarm signal". According to the BKK ProVita, the number of side effects is many times higher than those officially announced by the Paul Ehrlich Institute (PEI). A letter to the PEI (available to the Berliner Zeitung) states: "In our opinion, there is a significant underreporting of the side effects of the vaccination". The board of directors of BKK ProVita, Andreas Schöfbeck, said to the world: "According to our calculations, we consider 400,000 visits to the doctor by our insured persons due to vaccination complications to be realistic to date."

        The health insurance company had the data of millions of insured persons of the BKK group analyzed. Based on the evaluated data, Schöfbeck also comes to the conclusion that "a risk to human life cannot be ruled out". Schöfbeck has now sent a letter to Prof. Dr. Klaus Cichutek, the President of the Paul Ehrlich Institute. The letter also went to the National Association of Statutory Health Insurance Funds, the German Medical Association, the National Association of Statutory Health Insurance Physicians, the Standing Vaccination Commission and the BKK umbrella organization. The Berliner Zeitung publishes the letter with the headline "Strong warning signal for coded vaccination side effects after Corona vaccination".

        The letter in full:

        "Dear Prof. Dr. Cichutek, the Paul Ehrlich Institute, announced in a press release that 244,576 suspected cases of vaccination side effects after corona vaccination were reported for the 2021 calendar year. The data available to our company give us reason to assume that there is a very significant underreporting of suspected cases of vaccination side effects after corona vaccination. I am enclosing an evaluation with my letter.

        The data basis for our evaluation is the billing data of the doctors. Our sample is taken from the anonymized database of the company health insurance funds. The sample includes 10,937,716 insured persons. So far, we have the doctors’ billing data for the first half of 2021 and about half for the third quarter of 2021. Our query contains the valid ICD codes for vaccination side effects. This evaluation has shown, although we do not yet have the complete data for 2021, that based on the available figures, we are already assuming 216,695 treated cases of vaccination side effects after corona vaccination from this sample.

        If these figures are extrapolated to the year as a whole and to the population in Germany, it is likely that 2.5-3 million people in Germany received medical treatment because of side effects of vaccination after the Corona vaccination. We see this as a significant alarm signal that must be taken into account when the vaccines are used further. In our opinion, the figures can be validated relatively easily and also at short notice by asking the other types of insurance (AOKen, substitute health insurance companies, etc.) to evaluate the data available to them accordingly. Extrapolated to the number of vaccinated people in Germany, this means that around 4-5 percent of the vaccinated people were in medical treatment because of vaccination side effects.

        In our opinion, there is a significant underreporting of vaccination side effects. It is important to identify the causes of this in the short term. Our first assumption is that since no remuneration is paid for reporting side effects of vaccinations, the Paul Ehrlich Institute is often not reported because of the great effort involved. Doctors have reported to us that it takes about half an hour to report suspected vaccine damage. This means that 3 million suspected cases of vaccination side effects require around 1.5 million working hours for doctors. That would be almost the annual workload of 1,000 doctors. This should also be clarified in the short term.

        Therefore, a copy of this letter is also sent to the German Medical Association and the National Association of Statutory Health Insurance Physicians. The National Association of Statutory Health Insurance Funds also receives a copy of this letter with the request to obtain appropriate data analyzes from all health insurance companies. Since danger to human life cannot be ruled out, we would ask you to respond to the measures taken by February 22, 2022, 6 p.m.

        Kind regards

        Andreas Schöfbeck Board of Directors

        Die Krankenkasse BKK hat Millionen Versicherten-Daten ausgewertet. Die angegebenen Fallzahlen des Paul-Ehrlich-Instituts zu Impffolgen sind demnach zu niedrig.

        Comment


      • bump this

        Comment


        • Embarrassing ignorance or insidious intent to deceive - I don't know what prompted the board of BKK ProVita to warn of alleged alarm figures for vaccination complications. In any case, the conclusions from the data situation are complete nonsense”. With these clear words, Dr. Dirk Heinrich, the federal chairman of the Association of Resident Doctors (Virchowbund), the letter from the health insurance company BKK ProVita to the Paul Ehrlich Institute (PEI), which leaked to the media yesterday. In this letter, the insurance company claims to have found a “significant underreporting of the side effects of the vaccination”.

          However, the BKK ProVita mixes two completely different areas: the medical diagnosis coding with ICD codes and the notification to the PEI. The ICD code U12.9, which is recommended for documentation, should be given, for example, for 'Adverse reactions to the use of COVID-19 vaccines, unspecified'. However, “undesirable” and “unspecified” encompass the full range of expected, mild and temporary consequences of vaccination, e.g. B. a slight swelling at the injection site or increased temperature due to the immune response. There can therefore be no talk of a “danger to human life”, as the cash register puts it. The ICD codes also primarily serve the purpose of billing for medical services.

          If, on the other hand, there is a suspicion of side effects 'beyond the usual level', doctors are obliged to report this to the PEI. 'That's a blatant difference that the cash register here lets fall under the table. Just as you cannot simply equate the number of suspected cases with the number of confirmed side effects,' explains Dr. Heinrich. 'In addition, a whole series of ICD codes are lumped together during the 'evaluation', according to the motto: the more, the better.'

          'But this undifferentiated swearing obviously fits into the brand image of the health insurance company, which advertises homeopathy and osteopathy as statutory services and calls itself the 'most veggie-friendly health insurance company'. Apparently you want to do advertising in the vaccination-critical clientele.”

          The Virchowbund is the only free medical association that exclusively represents the interests of all doctors willing to practice, established and outpatient doctors of all disciplines.

          „Peinliches Unwissen oder hinterlistige Täuschungsabsicht – was davon den Vorstand der BKK ProVita bewogen hat, vor angeblichen Alarmzahlen bei Impfkomplikationen zu warnen, weiß ich nicht. Die Schlussfolgerungen aus der Datenlage sind jedenfalls kompletter Unfug“. Mit diesen deutlichen Worten kritisiert Dr. Dirk Heinrich, der Bundesvorsitzende des Verbandes der niedergelassenen Ärztinnen und Ärzte (Virchowbund), das Schreiben der Krankenkasse BKK ProVita an das Paul-Ehrlich-Institut (PEI), das gestern in die Medien durchsickerte. In diesem Brief will die Kasse eine „erhebliche Untererfassung der Impfnebenwirkungen“ festgestellt haben.

          Comment


          • Translation Google

            Debate about “underreporting”

            More vaccination side effects than known? Health insurance data cause discussions

            FOCUS Online editor Sebastian Viehmann
            Friday, 02/25/2022, 09:55

            The board of directors of the health insurance company BKK ProVita sees an “alarm signal” for side effects of the Covid 19 vaccinations. The AOK does not confirm this - but criticizes the data situation. Doctors certainly see the danger that suspected cases will not be recognized or reported.

            A "vaccination with almost no side effects" - this is how Federal Minister of Health Karl Lauterbach described the Covid-19 vaccine several times. The board of directors of the health insurance company BKK ProVita sees it differently after looking at his billing data: In an interview with the "Welt" Andreas Schöfbeck speaks of an alarm signal after the evaluation of millions of insured persons' data.

            "The total number of side effects is therefore many times higher than those reported by the Paul Ehrlich Institute (PEI)," writes the "Welt". From the beginning of 2021 to the middle of the third quarter, 216,695 BKK policyholders were treated for side effects from vaccines.

            The evaluation is also available to FOCUS Online. It remains unclear how serious or harmless the side effects were - in any case, these are cases that have been medically clarified or were associated with hospitalization.

            Health insurance data leave questions unanswered

            A causal connection with the vaccination has not been proven - and the data does not say whether the vaccination really caused damage or whether the complications were only of short duration.

            The PEI said on request that it is currently not possible to assess the data from the BKK, "because the institute has not yet had access to the original data and it also has no information on the evaluation method". Billing data should not be equated with side effects. The BKK umbrella organization stated in a statement that they distanced themselves from the data evaluation and did not want to comment on the content because the data did not come from the umbrella organization.

            Virchowbund criticizes "Schwurbel-BKK" - PEI wants to link data

            The Virchowbund, which represents resident doctors, criticized the "Schwurbel-BKK" with unusual sharpness and thus put Schöfbeck in the vicinity of lateral thinkers: It was either about "embarrassing ignorance or insidious intent to deceive". The conclusions from the data are "complete nonsense," said Federal Chairman Dirk Heinrich. The BKK Provita mixes two completely different areas: the medical diagnosis coding and the report to the PEI. "Apparently you want to do advertising in the vaccination-critical clientele."

            However, the PEI apparently takes the warning signal seriously: In order to analyze possible side effects of vaccines even better, the official vaccination quotas are to be linked in a study with data from the health insurance companies, the institute told the dpa. It should start promptly.
            ...
            The BKK board stands by its statement

            Schöfbeck sticks to his statements and confirms to FOCUS Online that the PEI has announced a conversation with him in the coming week, in which he should present his view of things. "According to our calculations, we consider 400,000 visits to the doctor by our insured persons due to vaccination complications to be realistic to this day," said Schöfbeck of the "Welt", "extrapolated to the total population, this value would be three million."

            The letter to the PEI, which is available to FOCUS Online, says literally: " Our query includes the valid ICD codes for vaccination side effects. This evaluation has shown that, although we do not yet have the complete data for 2021, we can already use the available numbers of 216,695 treated cases of side effects of vaccination after corona vaccination from this sample. If these figures are extrapolated to the year as a whole and to the population in Germany, there are probably 2.5-3 million people in Germany who are receiving medical treatment because of side effects of vaccination after corona vaccination We see that as a significant alarm signal that must be taken into account when the vaccines are used further. "

            An evaluation by the BKK ProVita for 10.9 million insured persons of the BKK health insurance companies sees a comparatively high number of vaccination side effects with Covid19 vaccines
            BKK ProVitaAn evaluation by the BKK ProVita for 10.9 million insured persons of the BKK health insurance companies sees a comparatively high number of vaccination side effects with Covid19 vaccines
            ...
            It is striking that this number of 10.9 million insured persons - according to the annual report, BKK ProVita itself only has around 125,000 members, but Schöfbeck says it got its data from a common data pool of all BKK insurance companies - is only around 30,000 lower than that Total number of all side effects registered by the PEI for around 64 million vaccinated people throughout Germany. So if Schöfbeck's data are truly representative of the general population, that would suggest a significant underreporting of vaccination complications.

            AOK on vaccination side effects: Limited meaningfulness of the data

            But how big is the problem really? Can't say yet. FOCUS Online asked the major health insurance companies AOK, Barmer and TKK whether they saw similar alarm signals as BKK ProVita. Barmer cannot provide any data: "We have no relevant analysis," explains a spokesman.
            ...
            The AOK answers in more detail. " We cannot assess the data basis and methodology of this evaluation, from which the BKK umbrella organization has since distanced itself. Basically, the billing data of the health insurance companies have only had a very limited meaningfulness on this topic, because the information about which of their insured persons were vaccinated when and with which vaccine is not available to the statutory health insurance companies at the moment," writes the health insurance company FOCUS Online.

            The evaluation of the data is difficult anyway: " The evaluation of the billing code 'U12.9: Undesirable side effects when using Covid-19 vaccines' does not allow any valid statements for the above reasons and is methodologically questionable because the results are not in relation to the number of vaccinations carried out and can be assigned to a suitable control group. In addition, such an evaluation does not provide any information on whether the side effect is mild or severe, ”continues the AOK.

            “Some serious side effects”

            Occasionally, severe side effects of vaccinations occur. “ At AstraZeneca, for example, it is sinus vein thrombosis, at BionTech and Moderna it is myocarditis and pericarditis (less than 1 case per 10,000 people). Young men and male children and adolescents aged 12 to 17 years are particularly affected after the second dose ,” the AOK continues. However, this has long been known.
            ...

            Side Effects: The Problem of Underreporting

            It seems unusual that, despite the massive dimensions of the vaccination campaign, elementary data are still missing to assess the situation. This refers less to the vaccination reactions experienced almost millions of times, such as fever , tiredness or skin reactions, which quickly subside and are harmless . Above all, it refers to the significant side effects that require medical treatment and, in the worst case, cause consequential damage. Only these cases were considered in his data analysis at all, says BKK Board Schöfbeck FOCUS Online.
            ...
            Not every vaccination reaction is a real side effect

            FOCUS Online had already interviewed several doctors who carry out vaccinations on the subject of child vaccination in the summer of 2021 . Some report that the number of side effects observed in adults is quite significant compared to other vaccines. But there is another point they made: are all side effects recognized and reported as such?

            Because, similar to Covid-19 diseases, it is not about dramatic individual cases, but whether the scope of side effects in relation to all of those vaccinated (or the Covid diseases in relation to all of those infected) is correctly assessed.

            The German Society for Child and Adolescent Medicine said to FOCUS Online in the summer: " All registration systems for vaccination complications are not based on epidemiological (i.e. population-related) studies, but only on individual observations that are reported to the registration bodies such as the Paul-Ehrlich institute in Germany. An exact estimate of the frequency of vaccination complications is therefore hardly possible. There is a risk of so-called underreporting, which means that complications are systematically underestimated.”

            Great responsibility of doctors

            The problem: the PEI registers the reported side effect reports, but can of course only send out an alarm signal if the number of reported cases - for example the number of heart muscle inflammations or pulmonary artery embolisms in a certain age group - is significantly lower than the number of statistically expected cases deviates. The greater the underreporting or underreporting, the greater the risk that the alarm bell will not ring in the first place.
            ...
            On the other hand, reporting suspected cases too carelessly could falsify the positive effect of the vaccination. This lies in a significant reduction in the severity of the disease when someone falls ill with Covid-19. The older the person, the clearer the risk-benefit ratio is in favor of vaccination.

            Doctors could therefore jeopardize the success of the vaccination campaign if they frequently sound the false alarm and then do not vaccinate people who are at high risk of Covid.

            Doctors report an increase in suspected cases

            Several clinic doctors and resident doctors have reported to FOCUS Online in recent weeks about an increase in suspected cases that they have reported to the PEI. Two examples:

            The senior physician of a clinic in North Rhine-Westphalia systematically records the vaccination status of his patients and reports eight pulmonary artery embolisms in temporal connection with the vaccination or the booster. "It was boosted four times with Moderna," said the doctor. He fears that many doctors do not even recognize a possible connection: even at the "upper decision-making level" the topic "has not yet arrived".
            A neurologist from northern Germany who works in a stroke unit (a special ambulance for neurological emergencies) reports a "massive increase" in emergency admissions. It mainly affects middle-aged to younger women who have severe mental disorders or severe headaches after the vaccinationcomplained. The suspicion of sinus vein thrombosis has only been confirmed in a few cases - a vaccination complication that has been known since 2021, but is extremely rare. Only one death is known to him. "But these people are still ill and in need of treatment," said the doctor. Also striking: “We have had three cases of Guillain-Barré syndrome since the start of the vaccination campaign. Normally, I see something like this at most once a year,” the neurologist reported. The syndrome is a severe neurological disease caused by overshooting of the immune system, for which, according to the German Society for Neurology, a causal connection with the vaccination is not certain, but is suspected.
            According to several doctors, it is more difficult to assess neurological emergencies in older patients, such as strokes occurring in connection with the vaccination. Since these clinical pictures occur more frequently in old and previously ill people, one should not assume a connection with the vaccination in case of doubt.

            "Message form is too complex"

            The physicians interviewed by FOCUS Online say unanimously that they consider the reporting scheme for side effects to be too complex. In view of the high number of vaccinations, a "low-threshold reporting system" is desirable. Doctors and nurses often simply do not have the time to document suspected cases in detail in everyday life, which is already characterized by bureaucracy.

            In its statement, the AOK also admits that the whole topic is ultimately being discussed on the basis of insufficient data: " Even if the health insurance companies had the information about vaccinations carried out, one could only use this to determine the frequency of serious side effects (sinus vein thrombosis, myocarditis, pericarditis) in the Assess comparison to appropriate control groups. Because only with these severe side effects can it be expected that they will also be documented in a differentiated manner in the billing data ”. After all: This merging of data should now exist according to the PEI.

            https://www.focus.de/gesundheit/mehr..._58570561.html

            Comment


            • Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line


              Abstract

              Preclinical studies of COVID-19 mRNA vaccine BNT162b2, developed by Pfizer and BioNTech, showed reversible hepatic effects in animals that received the BNT162b2 injection. Furthermore, a recent study showed that SARS-CoV-2 RNA can be reverse-transcribed and integrated into the genome of human cells. In this study, we investigated the effect of BNT162b2 on the human liver cell line Huh7 in vitro. Huh7 cells were exposed to BNT162b2, and quantitative PCR was performed on RNA extracted from the cells. We detected high levels of BNT162b2 in Huh7 cells and changes in gene expression of long interspersed nuclear element-1 (LINE-1), which is an endogenous reverse transcriptase. Immunohistochemistry using antibody binding to LINE-1 open reading frame-1 RNA-binding protein (ORFp1) on Huh7 cells treated with BNT162b2 indicated increased nucleus distribution of LINE-1. PCR on genomic DNA of Huh7 cells exposed to BNT162b2 amplified the DNA sequence unique to BNT162b2. Our results indicate a fast up-take of BNT162b2 into human liver cell line Huh7, leading to changes in LINE-1 expression and distribution. We also show that BNT162b2 mRNA is reverse transcribed intracellularly into DNA in as fast as 6 h upon BNT162b2 exposure.

              -snip-

              BNT162b2 is a lipid nanoparticle (LNP)–encapsulated, nucleoside-modified RNA vaccine (modRNA) and encodes the full-length of SARS-CoV-2 spike (S) protein, modified by two proline mutations to ensure antigenically optimal pre-fusion conformation, which mimics the intact virus to elicit virus-neutralizing antibodies [3]. Consistent with randomized clinical trials, BNT162b2 showed high efficiency in a wide range of COVID-19-related outcomes in a real-world setting [5]. Nevertheless, many challenges remain, including monitoring for long-term safety and efficacy of the vaccine. This warrants further evaluation and investigations. The safety profile of BNT162b2 is currently only available from short-term clinical studies. Less common adverse effects of BNT162b2 have been reported, including pericarditis, arrhythmia, deep-vein thrombosis, pulmonary embolism, myocardial infarction, intracranial hemorrhage, and thrombocytopenia [4,9,10,11,12,13,14,15,16,17,18,19,20]. There are also studies that report adverse effects observed in other types of vaccines [21,22,23,24]. To better understand mechanisms underlying vaccine-related adverse effects, clinical investigations as well as cellular and molecular analyses are needed.

              A recent study showed that SARS-CoV-2 RNAs can be reverse-transcribed and integrated into the genome of human cells [25]. This gives rise to the question of if this may also occur with BNT162b2, which encodes partial SARS-CoV-2 RNA. In pharmacokinetics data provided by Pfizer to European Medicines Agency (EMA), BNT162b2 biodistribution was studied in mice and rats by intra-muscular injection with radiolabeled LNP and luciferase modRNA. Radioactivity was detected in most tissues from the first time point (0.25 h), and results showed that the injection site and the liver were the major sites of distribution, with maximum concentrations observed at 8–48 h post-dose [26]. Furthermore, in animals that received the BNT162b2 injection, reversible hepatic effects were observed, including enlarged liver, vacuolation, increased gamma glutamyl transferase (γGT) levels, and increased levels of aspartate transaminase (AST) and alkaline phosphatase (ALP) [26]. Transient hepatic effects induced by LNP delivery systems have been reported previously [27,28,29,30], nevertheless, it has also been shown that the empty LNP without modRNA alone does not introduce any significant liver injury [27]. Therefore, in this study, we aim to examine the effect of BNT162b2 on a human liver cell line in vitro and investigate if BNT162b2 can be reverse transcribed into DNA through endogenous mechanisms.

              -snip-

              4. Discussion

              In this study we present evidence that COVID-19 mRNA vaccine BNT162b2 is able to enter the human liver cell line Huh7 in vitro. BNT162b2 mRNA is reverse transcribed intracellularly into DNA as fast as 6 h after BNT162b2 exposure. A possible mechanism for reverse transcription is through endogenous reverse transcriptase LINE-1, and the nucleus protein distribution of LINE-1 is elevated by BNT162b2.

              -snip-

              5. Conclusions

              Our study is the first in vitro study on the effect of COVID-19 mRNA vaccine BNT162b2 on human liver cell line. We present evidence on fast entry of BNT162b2 into the cells and subsequent intracellular reverse transcription of BNT162b2 mRNA into DNA.

              Comment


              • bump this

                Comment


                • I posted this story on this thread when it first broke and was published in the BJM. Now, a district court judge has unsealed the complaint along with all of the exhibits.

                  The second link posted here has 140 pages of documents and exhibits embedded that expose Pfizer's fraud.
                  It is really quite unnerving to realize what Pfizer knew regarding vaccine dangers and side effects and to what lengths they went to cover it up.

                  "The decision by a district court judge to unseal a complaint filed more than a year ago against multiple parties involved in Pfizer’s COVID vaccine trials allowed the lawsuit to go forward — and revealed 400 pages of exhibits used to substantiate the lawsuit’s claims.

                  A whistleblower lawsuit alleging fraud during Pfizer’s COVID vaccine trials is moving forward, after a district court judge unsealed the complaint, including 400 pages of exhibits.

                  Brook Jackson in January 2021 sued Pfizer and two companies the drugmaker contracted with to work on the trials: Ventavia Research Group and ICON PLC.

                  Jackson worked for Ventavia for a brief period in 2020 before being fired after she filed a complaint with the U.S. Food and Drug Administration (FDA) over alleged improprieties she observed during the vaccine trials.

                  She also gave The BMJ a cache of internal company documents, photos and recordings highlighting alleged wrongdoing by Ventavia."


                  March 1, 2022
                  Judge Unseals 400 Pages of Evidence, Clears Way for Pfizer Whistleblower Lawsuit
                  https://childrenshealthdefense.org/d...c-f5b50cb8275d

                  Pfizer Trial Whistleblower Presses Forward With Lawsuit Without US Government’s Help
                  https://yournews.com/2022/02/15/2299...s-governments/
                  The full sets of documents are embedded; the article continues below them.

                  Dec. 2, 2021
                  Pfizer Whistleblower Exposes Vaccine Data Cover-Up
                  https://tapnewswire.com/2021/12/pfiz...data-cover-up/

                  Brook Jackson Interview - Pfizer Whistleblower Exposes Cover Up Calling Vaccine Data Into Question
                  https://odysee.com/@TLAVagabond:5/Br...view-12-2-21:e

                  Comment


                  • bump this

                    Comment


                    • SHOCKING AND APPALLING: Just look at this very long list of "adverse events of special interest" in Pfizer's very own safety data report!
                      See attachment for their data sets and tables. Keep in mind that Pfizer has been caught and is being sued for manipulating data sets to hide signals indicating the vaccines could be dangerous to human health.

                      BNT162b2
                      5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021

                      PAGE 30: APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST

                      Report Prepared by: Worldwide Safety Pfizer
                      BNT162b2
                      5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
                      APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST
                      1p36 deletion syndrome;2-Hydroxyglutaric aciduria;5'nucleotidase increased;Acoustic neuritis;Acquired C1 inhibitor deficiency;Acquired epidermolysis bullosa;Acquired epileptic aphasia;Acute cutaneous lupus erythematosus;Acute disseminated encephalomyelitis;Acute encephalitis with refractory, repetitive partial seizures;Acute febrile neutrophilic dermatosis;Acute flaccid myelitis;Acute haemorrhagic leukoencephalitis;Acute haemorrhagic oedema of infancy;Acute kidney injury;Acute macular outer retinopathy;Acute motor axonal neuropathy;Acute motor-sensory axonal neuropathy;Acute myocardial infarction;Acute respiratory distress syndrome;Acute respiratory failure;Addison's disease;Administration site thrombosis;Administration site vasculitis;Adrenal thrombosis;Adverse event following immunisation;Ageusia;Agranulocytosis;Air embolism;Alanine aminotransferase abnormal;Alanine aminotransferase increased;Alcoholic seizure;Allergic bronchopulmonary mycosis;Allergic oedema;Alloimmune hepatitis;Alopecia areata;Alpers disease;Alveolar proteinosis;Ammonia abnormal;Ammonia increased;Amniotic cavity infection;Amygdalohippocampectomy;Amyloid arthropathy;Amyloidosis;Amyloidosis senile;Anaphylactic reaction;Anaphylactic shock;Anaphylactic transfusion reaction;Anaphylactoid reaction;Anaphylactoid shock;Anaphylactoid syndrome of pregnancy;Angioedema;Angiopathic neuropathy;Ankylosing spondylitis;Anosmia;Antiacetylcholine receptor antibody positive;Anti-actin antibody positive;Anti-aquaporin-4 antibody positive;Anti-basal ganglia antibody positive;Anti-cyclic citrullinated peptide antibody positive;Anti-epithelial antibody positive;Anti-erythrocyte antibody positive;Anti-exosome complex antibody positive;Anti- GAD antibody negative;Anti-GAD antibody positive;Anti-ganglioside antibody positive;Antigliadin antibody positive;Anti-glomerular basement membrane antibody positive;Anti-glomerular basement membrane disease;Anti-glycyl-tRNA synthetase antibody positive;Anti-HLA antibody test positive;Anti-IA2 antibody positive;Anti-insulin antibody increased;Anti-insulin antibody positive;Anti-insulin receptor antibody increased;Anti- insulin receptor antibody positive;Anti-interferon antibody negative;Anti-interferon antibody positive;Anti-islet cell antibody positive;Antimitochondrial antibody positive;Anti-muscle specific kinase antibody positive;Anti-myelin-associated glycoprotein antibodies positive;Anti-myelin-associated glycoprotein associated polyneuropathy;Antimyocardial antibody positive;Anti-neuronal antibody positive;Antineutrophil cytoplasmic antibody increased;Antineutrophil cytoplasmic antibody positive;Anti-neutrophil cytoplasmic antibody positive vasculitis;Anti-NMDA antibody positive;Antinuclear antibody increased;Antinuclear antibody positive;Antiphospholipid antibodies positive;Antiphospholipid syndrome;Anti-platelet antibody positive;Anti-prothrombin antibody positive;Antiribosomal P antibody positive;Anti-RNA polymerase III antibody positive;Anti-saccharomyces cerevisiae antibody test positive;Anti-sperm antibody positive;Anti-SRP antibody positive;Antisynthetase syndrome;Anti-thyroid antibody positive;Anti-transglutaminase antibody increased;Anti-VGCC antibody positive;Anti- VGKC antibody positive;Anti-vimentin antibody positive;Antiviral prophylaxis;Antiviral treatment;Anti-zinc transporter 8 antibody positive;Aortic embolus;Aortic thrombosis;Aortitis;Aplasia pure red cell;Aplastic anaemia;Application site thrombosis;Application site vasculitis;Arrhythmia;Arterial bypass occlusion;Arterial bypass thrombosis;Arterial thrombosis;Arteriovenous fistula thrombosis;Arteriovenous graft site stenosis;Arteriovenous graft thrombosis;Arteritis;Arteritis:
                      coronary;Arthralgia;Arthritis;Arthritis enteropathic;Ascites;Aseptic cavernous sinus thrombosis;Aspartate aminotransferase abnormal;Aspartate aminotransferase increased;Aspartate-glutamate-transporter deficiency;AST to platelet ratio index increased;AST/ALT ratio abnormal;Asthma;Asymptomatic COVID- 19;Ataxia;Atheroembolism;Atonic seizures;Atrial thrombosis;Atrophic thyroiditis;Atypical benign partial epilepsy;Atypical pneumonia;Aura;Autoantibody positive;Autoimmune anaemia;Autoimmune aplastic anaemia;Autoimmune arthritis;Autoimmune blistering disease;Autoimmune cholangitis;Autoimmune colitis;Autoimmune demyelinating disease;Autoimmune dermatitis;Autoimmune disorder;Autoimmune encephalopathy;Autoimmune endocrine disorder;Autoimmune enteropathy;Autoimmune eye disorder;Autoimmune haemolytic anaemia;Autoimmune heparin-induced thrombocytopenia;Autoimmune hepatitis;Autoimmune hyperlipidaemia;Autoimmune hypothyroidism;Autoimmune inner ear disease;Autoimmune lung disease;Autoimmune lymphoproliferative syndrome;Autoimmune myocarditis;Autoimmune myositis;Autoimmune nephritis;Autoimmune neuropathy;Autoimmune neutropenia;Autoimmune pancreatitis;Autoimmune pancytopenia;Autoimmune pericarditis;Autoimmune retinopathy;Autoimmune thyroid disorder;Autoimmune thyroiditis;Autoimmune uveitis;Autoinflammation with infantile enterocolitis;Autoinflammatory disease;Automatism epileptic;Autonomic nervous system imbalance;Autonomic seizure;Axial spondyloarthritis;Axillary vein thrombosis;Axonal and demyelinating polyneuropathy;Axonal neuropathy;Bacterascites;Baltic myoclonic epilepsy;Band sensation;Basedow's disease;Basilar artery thrombosis;Basophilopenia;B-cell aplasia;Behcet's syndrome;Benign ethnic neutropenia;Benign familial neonatal convulsions;Benign familial pemphigus;Benign rolandic epilepsy;Beta-2 glycoprotein antibody positive;Bickerstaff's encephalitis;Bile output abnormal;Bile output decreased;Biliary ascites;Bilirubin conjugated abnormal;Bilirubin conjugated increased;Bilirubin urine present;Biopsy liver abnormal;Biotinidase deficiency;Birdshot chorioretinopathy;Blood alkaline phosphatase abnormal;Blood alkaline phosphatase increased;Blood bilirubin abnormal;Blood bilirubin increased;Blood bilirubin unconjugated increased;Blood cholinesterase abnormal;Blood cholinesterase decreased;Blood pressure decreased;Blood pressure diastolic decreased;Blood pressure systolic decreased;Blue toe syndrome;Brachiocephalic vein thrombosis;Brain stem embolism;Brain stem thrombosis;Bromosulphthalein test abnormal;Bronchial oedema;Bronchitis;Bronchitis mycoplasmal;Bronchitis viral;Bronchopulmonary aspergillosis allergic;Bronchospasm;Budd- Chiari syndrome;Bulbar palsy;Butterfly rash;C1q nephropathy;Caesarean section;Calcium embolism;Capillaritis;Caplan's syndrome;Cardiac amyloidosis;Cardiac arrest;Cardiac failure;Cardiac failure acute;Cardiac sarcoidosis;Cardiac ventricular thrombosis;Cardiogenic shock;Cardiolipin antibody positive;Cardiopulmonary failure;Cardio-respiratory arrest;Cardio-respiratory distress;Cardiovascular insufficiency;Carotid arterial embolus;Carotid artery thrombosis;Cataplexy;Catheter site thrombosis;Catheter site vasculitis;Cavernous sinus thrombosis;CDKL5 deficiency disorder;CEC syndrome;Cement embolism;Central nervous system lupus;Central nervous system vasculitis;Cerebellar artery thrombosis;Cerebellar embolism;Cerebral amyloid angiopathy;Cerebral arteritis;Cerebral artery embolism;Cerebral artery thrombosis;Cerebral gas embolism;Cerebral microembolism;Cerebral septic infarct;Cerebral thrombosis;Cerebral venous sinus thrombosis;Cerebral venous thrombosis;Cerebrospinal thrombotic tamponade;Cerebrovascular accident;Change in seizure presentation;Chest discomfort;Child- Pugh-Turcotte score abnormal;Child-Pugh-Turcotte score increased;Chillblains;Choking;Choking sensation;Cholangitis sclerosing;Chronic autoimmune glomerulonephritis;Chronic cutaneous lupus erythematosus;Chronic fatigue syndrome;Chronic gastritis;Chronic inflammatory demyelinating polyradiculoneuropathy;Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids;Chronic recurrent multifocal osteomyelitis;Chronic respiratory failure;Chronic spontaneous urticaria;Circulatory collapse;Circumoral oedema;Circumoral swelling;Clinically isolated syndrome;Clonic convulsion;Coeliac disease;Cogan's syndrome;Cold agglutinins positive;Cold type haemolytic anaemia;Colitis;Colitis erosive;Colitis herpes;Colitis microscopic;Colitis ulcerative;Collagen disorder;Collagen-vascular disease;Complement factor abnormal;Complement factor C1 decreased;Complement factor C2 decreased;Complement factor C3 decreased;Complement factor C4 decreased;Complement factor decreased;Computerised tomogram liver abnormal;Concentric sclerosis;Congenital anomaly;Congenital bilateral perisylvian syndrome;Congenital herpes simplex infection;Congenital myasthenic syndrome;Congenital varicella infection;Congestive hepatopathy;Convulsion in childhood;Convulsions local;Convulsive threshold lowered;Coombs positive haemolytic anaemia;Coronary artery disease;Coronary artery embolism;Coronary artery thrombosis;Coronary bypass thrombosis;Coronavirus infection;Coronavirus test;Coronavirus test negative;Coronavirus test positive;Corpus callosotomy;Cough;Cough variant asthma;COVID-19;COVID-19 immunisation;COVID-19 pneumonia;COVID-19 prophylaxis;COVID-19 treatment;Cranial nerve disorder;Cranial nerve palsies multiple;Cranial nerve paralysis;CREST syndrome;Crohn's disease;Cryofibrinogenaemia;Cryoglobulinaemia;CSF oligoclonal band present;CSWS syndrome;Cutaneous amyloidosis;Cutaneous lupus erythematosus;Cutaneous sarcoidosis;Cutaneous vasculitis;Cyanosis;Cyclic neutropenia;Cystitis interstitial;Cytokine release syndrome;Cytokine storm;De novo purine synthesis inhibitors associated acute inflammatory syndrome;Death neonatal;Deep vein thrombosis;Deep vein thrombosis postoperative;Deficiency of bile secretion;Deja vu;Demyelinating polyneuropathy;Demyelination;Dermatitis;Dermatitis bullous;Dermatitis herpetiformis;Dermatomyositis;Device embolisation;Device related thrombosis;Diabetes mellitus;Diabetic ketoacidosis;Diabetic mastopathy;Dialysis amyloidosis;Dialysis membrane reaction;Diastolic hypotension;Diffuse vasculitis;Digital pitting scar;Disseminated intravascular coagulation;Disseminated intravascular coagulation in newborn;Disseminated neonatal herpes simplex;Disseminated varicella;Disseminated varicella zoster vaccine virus infection;Disseminated varicella zoster virus infection;DNA antibody positive;Double cortex syndrome;Double stranded DNA antibody positive;Dreamy state;Dressler's syndrome;Drop attacks;Drug withdrawal convulsions;Dyspnoea;Early infantile epileptic encephalopathy with burst-suppression;Eclampsia;Eczema herpeticum;Embolia cutis medicamentosa;Embolic cerebellar infarction;Embolic cerebral infarction;Embolic pneumonia;Embolic stroke;Embolism;Embolism arterial;Embolism venous;Encephalitis;Encephalitis allergic;Encephalitis autoimmune;Encephalitis brain stem;Encephalitis haemorrhagic;Encephalitis periaxialis diffusa;Encephalitis post immunisation;Encephalomyelitis;Encephalopathy;Endo crine disorder;Endocrine ophthalmopathy;Endotracheal intubation;Enteritis;Enteritis leukopenic;Enterobacter pneumonia;Enterocolitis;Enteropathic spondylitis;Eosinopenia;Eosinophilic fasciitis;Eosinophilic granulomatosis with polyangiitis;Eosinophilic oesophagitis;Epidermolysis;Epilepsy;Epilepsy surgery;Epilepsy with myoclonic-atonic seizures;Epileptic aura;Epileptic psychosis;Erythema;Erythema induratum;Erythema multiforme;Erythema nodosum;Evans syndrome;Exanthema subitum;Expanded disability status scale score decreased;Expanded disability status scale score increased;Exposure to communicable disease;Exposure to SARS-CoV-2;Eye oedema;Eye pruritus;Eye swelling;Eyelid oedema;Face oedema;Facial paralysis;Facial paresis;Faciobrachial dystonic seizure;Fat embolism;Febrile convulsion;Febrile infection-related epilepsy syndrome;Febrile neutropenia;Felty's syndrome;Femoral artery embolism;Fibrillary glomerulonephritis;Fibromyalgia;Flushing;Foaming at mouth;Focal cortical resection;Focal dyscognitive seizures;Foetal distress syndrome;Foetal placental thrombosis;Foetor hepaticus;Foreign body embolism;Frontal lobe epilepsy;Fulminant type 1 diabetes mellitus;Galactose elimination capacity test abnormal;Galactose elimination capacity test decreased;Gamma-glutamyltransferase abnormal;Gamma-glutamyltransferase increased;Gastritis herpes;Gastrointestinal amyloidosis;Gelastic seizure;Generalised onset non-motor seizure;Generalised tonic-clonic seizure;Genital herpes;Genital herpes simplex;Genital herpes zoster;Giant cell arteritis;Glomerulonephritis;Glomerulonephritis membranoproliferative;Glomerulonephritis membranous;Glomerulonephritis rapidly progressive;Glossopharyngeal nerve paralysis;Glucose transporter type 1 deficiency syndrome;Glutamate dehydrogenase increased;Glycocholic acid increased;GM2 gangliosidosis;Goodpasture's syndrome;Graft thrombosis;Granulocytopenia;Granulocytopenia neonatal;Granulomatosis with polyangiitis;Granulomatous dermatitis;Grey matter heterotopia;Guanase increased;Guillain- Barre syndrome;Haemolytic anaemia;Haemophagocytic lymphohistiocytosis;Haemorrhage;Haemorrhagic ascites;Haemorrhagic disorder;Haemorrhagic pneumonia;Haemorrhagic varicella syndrome;Haemorrhagic vasculitis;Hantavirus pulmonary infection;Hashimoto's encephalopathy;Hashitoxicosis;Hemimegalencephaly;H enoch-Schonlein purpura;Henoch- Schonlein purpura nephritis;Hepaplastin abnormal;Hepaplastin decreased;Heparin-induced thrombocytopenia;Hepatic amyloidosis;Hepatic artery embolism;Hepatic artery flow decreased;Hepatic artery thrombosis;Hepatic enzyme abnormal;Hepatic enzyme decreased;Hepatic enzyme increased;Hepatic fibrosis marker abnormal;Hepatic fibrosis marker increased;Hepatic function abnormal;Hepatic hydrothorax;Hepatic hypertrophy;Hepatic hypoperfusion;Hepatic lymphocytic infiltration;Hepatic mass;Hepatic pain;Hepatic sequestration;Hepatic vascular resistance increased;Hepatic vascular thrombosis;Hepatic vein embolism;Hepatic vein thrombosis;Hepatic venous pressure gradient abnormal;Hepatic venous pressure gradient increased;Hepatitis;Hepatobiliary scan abnormal;Hepatomegaly;Hepatosplenomegaly;Hereditar y angioedema with C1 esterase inhibitor deficiency;Herpes dermatitis;Herpes gestationis;Herpes oesophagitis;Herpes ophthalmic;Herpes pharyngitis;Herpes sepsis;Herpes simplex;Herpes simplex cervicitis;Herpes simplex colitis;Herpes simplex encephalitis;Herpes simplex gastritis;Herpes simplex hepatitis;Herpes simplex meningitis;Herpes simplex meningoencephalitis;Herpes simplex meningomyelitis;Herpes simplex necrotising retinopathy;Herpes simplex oesophagitis;Herpes simplex otitis externa;Herpes simplex pharyngitis;Herpes simplex pneumonia;Herpes simplex reactivation;Herpes simplex sepsis;Herpes simplex viraemia;Herpes simplex virus conjunctivitis neonatal;Herpes simplex visceral;Herpes virus infection;Herpes zoster;Herpes zoster cutaneous disseminated;Herpes zoster infection neurological;Herpes zoster meningitis;Herpes zoster meningoencephalitis;Herpes zoster meningomyelitis;Herpes zoster meningoradiculitis;Herpes zoster necrotising retinopathy;Herpes zoster oticus;Herpes zoster pharyngitis;Herpes zoster reactivation;Herpetic radiculopathy;Histone antibody positive;Hoigne's syndrome;Human herpesvirus 6 encephalitis;Human herpesvirus 6 infection;Human herpesvirus 6 infection reactivation;Human herpesvirus 7 infection;Human herpesvirus 8 infection;Hyperammonaemia;Hyperbilirubinaemia;Hype rcholia;Hypergammaglobulinaemia benign monoclonal;Hyperglycaemic seizure;Hypersensitivity;Hypersensitivity vasculitis;Hyperthyroidism;Hypertransaminasaemia;H yperventilation;Hypoalbuminaemia;H ypocalcaemic seizure;Hypogammaglobulinaemia;Hypoglossal nerve paralysis;Hypoglossal nerve paresis;Hypoglycaemic seizure;Hyponatraemic seizure;Hypotension;Hypotensive crisis;Hypothenar hammer syndrome;Hypothyroidism;Hypoxia;Idiopathic CD4 lymphocytopenia;Idiopathic generalised epilepsy;Idiopathic interstitial pneumonia;Idiopathic neutropenia;Idiopathic pulmonary fibrosis;IgA nephropathy;IgM nephropathy;IIIrd nerve paralysis;IIIrd nerve paresis;Iliac artery embolism;Immune thrombocytopenia;Immune- mediated adverse reaction;Immune-mediated cholangitis;Immune-mediated cholestasis;Immune-mediated cytopenia;Immune-mediated encephalitis;Immune-mediated encephalopathy;Immune-mediated endocrinopathy;Immune-mediated enterocolitis;Immune- mediated gastritis;Immune-mediated hepatic disorder;Immune-mediated hepatitis;Immune- mediated hyperthyroidism;Immune-mediated hypothyroidism;Immune-mediated myocarditis;Immune-mediated myositis;Immune-mediated nephritis;Immune-mediated neuropathy;Immune-mediated pancreatitis;Immune-mediated pneumonitis;Immune-mediated renal disorder;Immune-mediated thyroiditis;Immune-mediated uveitis;Immunoglobulin G4 related disease;Immunoglobulins abnormal;Implant site thrombosis;Inclusion body myositis;Infantile genetic agranulocytosis;Infantile spasms;Infected vasculitis;Infective thrombosis;Inflammation;Inflammatory bowel disease;Infusion site thrombosis;Infusion site vasculitis;Injection site thrombosis;Injection site urticaria;Injection site vasculitis;Instillation site thrombosis;Insulin autoimmune syndrome;Interstitial granulomatous dermatitis;Interstitial lung disease;Intracardiac mass;Intracardiac thrombus;Intracranial pressure increased;Intrapericardial thrombosis;Intrinsic factor antibody abnormal;Intrinsic factor antibody positive;IPEX syndrome;Irregular breathing;IRVAN syndrome;IVth nerve paralysis;IVth nerve paresis;JC polyomavirus test positive;JC virus CSF test positive;Jeavons syndrome;Jugular vein embolism;Jugular vein thrombosis;Juvenile idiopathic arthritis;Juvenile myoclonic epilepsy;Juvenile polymyositis;Juvenile psoriatic arthritis;Juvenile spondyloarthritis;Kaposi sarcoma inflammatory cytokine syndrome;Kawasaki's disease;Kayser-Fleischer ring;Keratoderma blenorrhagica;Ketosis- prone diabetes mellitus;Kounis syndrome;Lafora's myoclonic epilepsy;Lambl's excrescences;Laryngeal dyspnoea;Laryngeal oedema;Laryngeal rheumatoid arthritis;Laryngospasm;Laryngotracheal oedema;Latent autoimmune diabetes in adults;LE cells present;Lemierre syndrome;Lennox-Gastaut syndrome;Leucine aminopeptidase increased;Leukoencephalomyelitis;Leukoencephalopat hy;Leukopenia;Leukopenia neonatal;Lewis-Sumner syndrome;Lhermitte's sign;Lichen planopilaris;Lichen planus;Lichen sclerosus;Limbic encephalitis;Linear IgA disease;Lip oedema;Lip swelling;Liver function test abnormal;Liver function test decreased;Liver function test increased;Liver induration;Liver injury;Liver iron concentration abnormal;Liver iron concentration increased;Liver opacity;Liver palpable;Liver sarcoidosis;Liver scan abnormal;Liver tenderness;Low birth weight baby;Lower respiratory tract herpes infection;Lower respiratory tract infection;Lower respiratory tract infection viral;Lung abscess;Lupoid hepatic cirrhosis;Lupus cystitis;Lupus encephalitis;Lupus endocarditis;Lupus enteritis;Lupus hepatitis;Lupus myocarditis;Lupus myositis;Lupus nephritis;Lupus pancreatitis;Lupus pleurisy;Lupus pneumonitis;Lupus vasculitis;Lupus-like syndrome;Lymphocytic hypophysitis;Lymphocytopenia neonatal;Lymphopenia;MAGIC syndrome;Magnetic resonance imaging liver abnormal;Magnetic resonance proton density fat fraction measurement;Mahler sign;Manufacturing laboratory analytical testing issue;Manufacturing materials issue;Manufacturing production issue;Marburg's variant multiple sclerosis;Marchiafava-Bignami disease;Marine Lenhart syndrome;Mastocytic enterocolitis;Maternal exposure during pregnancy;Medical device site thrombosis;Medical device site vasculitis;MELAS syndrome;Meningitis;Meningitis aseptic;Meningitis herpes;Meningoencephalitis herpes simplex neonatal;Meningoencephalitis herpetic;Meningomyelitis herpes;MERS-CoV test;MERS-CoV test negative;MERS-CoV test positive;Mesangioproliferative glomerulonephritis;Mesenteric artery embolism;Mesenteric artery thrombosis;Mesenteric vein thrombosis;Metapneumovirus infection;Metastatic cutaneous Crohn's disease;Metastatic pulmonary embolism;Microangiopathy;Microembolism;Microscopic polyangiitis;Middle East respiratory syndrome;Migraine-triggered seizure;Miliary pneumonia;Miller Fisher syndrome;Mitochondrial aspartate aminotransferase increased;Mixed connective tissue disease;Model for end stage liver disease score abnormal;Model for end stage liver disease score increased;Molar ratio of total branched-chain amino acid to tyrosine;Molybdenum cofactor deficiency;Monocytopenia;Mononeuritis;Mononeuropat hy multiplex;Morphoea;Morvan syndrome;Mouth swelling;Moyamoya disease;Multifocal motor neuropathy;Multiple organ dysfunction syndrome;Multiple sclerosis;Multiple sclerosis relapse;Multiple sclerosis relapse prophylaxis;Multiple subpial transection;Multisystem inflammatory syndrome in children;Muscular sarcoidosis;Myasthenia gravis;Myasthenia gravis crisis;Myasthenia gravis neonatal;Myasthenic syndrome;Myelitis;Myelitis transverse;Myocardial infarction;Myocarditis;Myocarditis post infection;Myoclonic epilepsy;Myoclonic epilepsy and ragged-red fibres;Myokymia;Myositis;Narcolepsy;Nasal herpes;Nasal obstruction;Necrotising herpetic retinopathy;Neonatal Crohn's disease;Neonatal epileptic seizure;Neonatal lupus erythematosus;Neonatal mucocutaneous herpes simplex;Neonatal pneumonia;Neonatal seizure;Nephritis;Nephrogenic systemic fibrosis;Neuralgic amyotrophy;Neuritis;Neuritis cranial;Neuromyelitis optica pseudo relapse;Neuromyelitis optica spectrum disorder;Neuromyotonia;Neuronal neuropathy;Neuropathy peripheral;Neuropathy, ataxia, retinitis pigmentosa syndrome;Neuropsychiatric lupus;Neurosarcoidosis;Neutropenia;Neutropenia neonatal;Neutropenic colitis;Neutropenic infection;Neutropenic sepsis;Nodular rash;Nodular vasculitis;Noninfectious myelitis;Noninfective encephalitis;Noninfective encephalomyelitis;Noninfective oophoritis;Obstetrical pulmonary embolism;Occupational exposure to communicable disease;Occupational exposure to SARS-CoV-2;Ocular hyperaemia;Ocular myasthenia;Ocular pemphigoid;Ocular sarcoidosis;Ocular vasculitis;Oculofacial paralysis;Oedema;Oedema blister;Oedema due to hepatic disease;Oedema mouth;Oesophageal achalasia;Ophthalmic artery thrombosis;Ophthalmic herpes simplex;Ophthalmic herpes zoster;Ophthalmic vein thrombosis;Optic neuritis;Optic neuropathy;Optic perineuritis;Oral herpes;Oral lichen planus;Oropharyngeal oedema;Oropharyngeal spasm;Oropharyngeal swelling;Osmotic demyelination syndrome;Ovarian vein thrombosis;Overlap syndrome;Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection;Paget-Schroetter syndrome;Palindromic rheumatism;Palisaded neutrophilic granulomatous dermatitis;Palmoplantar keratoderma;Palpable purpura;Pancreatitis;Panencephalitis;Papillophlebi tis;Paracancerous pneumonia;Paradoxical embolism;Parainfluenzae viral laryngotracheobronchitis;Paraneoplastic dermatomyositis;Paraneoplastic pemphigus;Paraneoplastic thrombosis;Paresis cranial nerve;Parietal cell antibody positive;Paroxysmal nocturnal haemoglobinuria;Partial seizures;Partial seizures with secondary generalisation;Patient isolation;Pelvic venous thrombosis;Pemphigoid;Pemphigus;Penile vein thrombosis;Pericarditis;Pericarditis lupus;Perihepatic discomfort;Periorbital oedema;Periorbital swelling;Peripheral artery thrombosis;Peripheral embolism;Peripheral ischaemia;Peripheral vein thrombus extension;Periportal oedema;Peritoneal fluid protein abnormal;Peritoneal fluid protein decreased;Peritoneal fluid protein increased;Peritonitis lupus;Pernicious anaemia;Petit mal epilepsy;Pharyngeal oedema;Pharyngeal swelling;Pityriasis lichenoides et varioliformis acuta;Placenta praevia;Pleuroparenchymal fibroelastosis;Pneumobilia;Pneumonia;Pneumonia adenoviral;Pneumonia cytomegaloviral;Pneumonia herpes viral;Pneumonia influenzal;Pneumonia measles;Pneumonia mycoplasmal;Pneumonia necrotising;Pneumonia parainfluenzae viral;Pneumonia respiratory syncytial viral;Pneumonia viral;POEMS syndrome;Polyarteritis nodosa;Polyarthritis;Polychondritis;Polyglandular autoimmune syndrome type I;Polyglandular autoimmune syndrome type II;Polyglandular autoimmune syndrome type III;Polyglandular disorder;Polymicrogyria;Polymyalgia rheumatica;Polymyositis;Polyneuropathy;Polyneuropa thy idiopathic progressive;Portal pyaemia;Portal vein embolism;Portal vein flow decreased;Portal vein pressure increased;Portal vein thrombosis;Portosplenomesenteric venous thrombosis;Post procedural hypotension;Post procedural pneumonia;Post procedural pulmonary embolism;Post stroke epilepsy;Post stroke seizure;Post thrombotic retinopathy;Post thrombotic syndrome;Post viral fatigue syndrome;Postictal headache;Postictal paralysis;Postictal psychosis;Postictal state;Postoperative respiratory distress;Postoperative respiratory failure;Postoperative thrombosis;Postpartum thrombosis;Postpartum venous thrombosis;Postpericardiotomy syndrome;Post-traumatic epilepsy;Postural orthostatic tachycardia syndrome;Precerebral artery thrombosis;Pre-eclampsia;Preictal state;Premature labour;Premature menopause;Primary amyloidosis;Primary biliary cholangitis;Primary progressive multiple sclerosis;Procedural shock;Proctitis herpes;Proctitis ulcerative;Product availability issue;Product distribution issue;Product supply issue;Progressive facial hemiatrophy;Progressive multifocal leukoencephalopathy;Progressive multiple sclerosis;Progressive relapsing multiple sclerosis;Prosthetic cardiac valve thrombosis;Pruritus;Pruritus allergic;Pseudovasculitis;Psoriasis;Psoriatic arthropathy;Pulmonary amyloidosis;Pulmonary artery thrombosis;Pulmonary embolism;Pulmonary fibrosis;Pulmonary haemorrhage;Pulmonary microemboli;Pulmonary oil microembolism;Pulmonary renal syndrome;Pulmonary sarcoidosis;Pulmonary sepsis;Pulmonary thrombosis;Pulmonary tumour thrombotic microangiopathy;Pulmonary vasculitis;Pulmonary veno-occlusive disease;Pulmonary venous thrombosis;Pyoderma gangrenosum;Pyostomatitis vegetans;Pyrexia;Quarantine;Radiation leukopenia;Radiculitis brachial;Radiologically isolated syndrome;Rash;Rash erythematous;Rash pruritic;Rasmussen encephalitis;Raynaud's phenomenon;Reactive capillary endothelial proliferation;Relapsing multiple sclerosis;Relapsing-remitting multiple sclerosis;Renal amyloidosis;Renal arteritis;Renal artery thrombosis;Renal embolism;Renal failure;Renal vascular thrombosis;Renal vasculitis;Renal vein embolism;Renal vein thrombosis;Respiratory arrest;Respiratory disorder;Respiratory distress;Respiratory failure;Respiratory paralysis;Respiratory syncytial virus bronchiolitis;Respiratory syncytial virus bronchitis;Retinal artery embolism;Retinal artery occlusion;Retinal artery thrombosis;Retinal vascular thrombosis;Retinal vasculitis;Retinal vein occlusion;Retinal vein thrombosis;Retinol binding protein decreased;Retinopathy;Retrograde portal vein flow;Retroperitoneal fibrosis;Reversible airways obstruction;Reynold's syndrome;Rheumatic brain disease;Rheumatic disorder;Rheumatoid arthritis;Rheumatoid factor increased;Rheumatoid factor positive;Rheumatoid factor quantitative increased;Rheumatoid lung;Rheumatoid neutrophilic dermatosis;Rheumatoid nodule;Rheumatoid nodule removal;Rheumatoid scleritis;Rheumatoid vasculitis;Saccadic eye movement;SAPHO syndrome;Sarcoidosis;SARS-CoV-1 test;SARS-CoV-1 test negative;SARS-CoV-1 test positive;SARS-CoV-2 antibody test;SARS-CoV-2 antibody test negative;SARS-CoV-2 antibody test positive;SARS-CoV-2 carrier;SARS-CoV-2 sepsis;SARS-CoV-2 test;SARS- CoV-2 test false negative;SARS-CoV-2 test false positive;SARS-CoV-2 test negative;SARS- CoV-2 test positive;SARS-CoV-2 viraemia;Satoyoshi syndrome;Schizencephaly;Scleritis;Sclerodactylia;S cleroderma;Scleroderma associated digital ulcer;Scleroderma renal crisis;Scleroderma-like reaction;Secondary amyloidosis;Secondary cerebellar degeneration;Secondary progressive multiple sclerosis;Segmented hyalinising vasculitis;Seizure;Seizure anoxic;Seizure cluster;Seizure like phenomena;Seizure prophylaxis;Sensation of foreign body;Septic embolus;Septic pulmonary embolism;Severe acute respiratory syndrome;Severe myoclonic epilepsy of infancy;Shock;Shock symptom;Shrinking lung syndrome;Shunt thrombosis;Silent thyroiditis;Simple partial seizures;Sjogren's syndrome;Skin swelling;SLE arthritis;Smooth muscle antibody positive;Sneezing;Spinal artery embolism;Spinal artery thrombosis;Splenic artery thrombosis;Splenic embolism;Splenic thrombosis;Splenic vein thrombosis;Spondylitis;Spondyloarthropathy;Spontan eous heparin-induced thrombocytopenia syndrome;Status epilepticus;Stevens-Johnson syndrome;Stiff leg syndrome;Stiff person syndrome;Stillbirth;Still's disease;Stoma site thrombosis;Stoma site vasculitis;Stress cardiomyopathy;Stridor;Subacute cutaneous lupus erythematosus;Subacute endocarditis;Subacute inflammatory demyelinating polyneuropathy;Subclavian artery embolism;Subclavian artery thrombosis;Subclavian vein thrombosis;Sudden unexplained death in epilepsy;Superior sagittal sinus thrombosis;Susac's syndrome;Suspected COVID- 19;Swelling;Swelling face;Swelling of eyelid;Swollen tongue;Sympathetic ophthalmia;Systemic lupus erythematosus;Systemic lupus erythematosus disease activity index abnormal;Systemic lupus erythematosus disease activity index decreased;Systemic lupus erythematosus disease activity index increased;Systemic lupus erythematosus rash;Systemic scleroderma;Systemic sclerosis pulmonary;Tachycardia;Tachypnoea;Takayasu's arteritis;Temporal lobe epilepsy;Terminal ileitis;Testicular autoimmunity;Throat tightness;Thromboangiitis obliterans;Thrombocytopenia;Thrombocytopenic purpura;Thrombophlebitis;Thrombophlebitis migrans;Thrombophlebitis
                      neonatal;Thrombophlebitis septic;Thrombophlebitis superficial;Thromboplastin antibody positive;Thrombosis;Thrombosis corpora cavernosa;Thrombosis in device;Thrombosis mesenteric vessel;Thrombotic cerebral infarction;Thrombotic microangiopathy;Thrombotic stroke;Thrombotic thrombocytopenic purpura;Thyroid disorder;Thyroid stimulating immunoglobulin increased;Thyroiditis;Tongue amyloidosis;Tongue biting;Tongue oedema;Tonic clonic movements;Tonic convulsion;Tonic posturing;Topectomy;Total bile acids increased;Toxic epidermal necrolysis;Toxic leukoencephalopathy;Toxic oil syndrome;Tracheal obstruction;Tracheal oedema;Tracheobronchitis;Tracheobronchitis mycoplasmal;Tracheobronchitis viral;Transaminases abnormal;Transaminases increased;Transfusion-related alloimmune neutropenia;Transient epileptic amnesia;Transverse sinus thrombosis;Trigeminal nerve paresis;Trigeminal neuralgia;Trigeminal palsy;Truncus coeliacus thrombosis;Tuberous sclerosis complex;Tubulointerstitial nephritis and uveitis syndrome;Tumefactive multiple sclerosis;Tumour embolism;Tumour thrombosis;Type 1 diabetes mellitus;Type I hypersensitivity;Type III immune complex mediated reaction;Uhthoff's phenomenon;Ulcerative keratitis;Ultrasound liver abnormal;Umbilical cord thrombosis;Uncinate fits;Undifferentiated connective tissue disease;Upper airway obstruction;Urine bilirubin increased;Urobilinogen urine decreased;Urobilinogen urine increased;Urticaria;Urticaria papular;Urticarial vasculitis;Uterine rupture;Uveitis;Vaccination site thrombosis;Vaccination site vasculitis;Vagus nerve paralysis;Varicella;Varicella keratitis;Varicella post vaccine;Varicella zoster gastritis;Varicella zoster oesophagitis;Varicella zoster pneumonia;Varicella zoster sepsis;Varicella zoster virus infection;Vasa praevia;Vascular graft thrombosis;Vascular pseudoaneurysm thrombosis;Vascular purpura;Vascular stent thrombosis;Vasculitic rash;Vasculitic ulcer;Vasculitis;Vasculitis gastrointestinal;Vasculitis necrotising;Vena cava embolism;Vena cava thrombosis;Venous intravasation;Venous recanalisation;Venous thrombosis;Venous thrombosis in pregnancy;Venous thrombosis limb;Venous thrombosis neonatal;Vertebral artery thrombosis;Vessel puncture site thrombosis;Visceral venous thrombosis;VIth nerve paralysis;VIth nerve paresis;Vitiligo;Vocal cord paralysis;Vocal cord paresis;Vogt-Koyanagi-Harada disease;Warm type haemolytic anaemia;Wheezing;White nipple sign;XIth nerve paralysis;X-ray hepatobiliary abnormal;Young's syndrome;Zika virus associated Guillain Barre syndrome.

                      CONFIDENTIAL Page 9

                      FDA-CBER-2021-5683-0000091
                      Attached Files

                      Comment


                      • sharon sanders
                        sharon sanders commented
                        Editing a comment
                        I think appendix 1 is a list of side that the company was MONITORING for - not the effects that occurred. As I understand it, this is now a public document published by the FDA in their CBER program for 2022. Also, a judge ordered release of some documents. https://www.fda.gov/vaccines-blood-b...ndar-year-2022

                      • sharon sanders
                        sharon sanders commented
                        Editing a comment
                        Please see post #120 below for rebuttal.

                    • A pro-vaccine analysis of the above. Like I have said many times - we are going to publish all sides of an issue. We do not do cancel culture.

                      IF YOU HAVE ANY MEDICAL QUESTIONS, INCLUDING VACCINES, CONSULT YOUR MEDICAL PRACTITIONER.


                      Edward Nirenberg 🇺🇦@ENirenberg
                      I see a lot of people sharing a document from Pfizer describing pharmacovigilance data from spontaneous reporting and the vast, vast majority of people are not interpreting it correctly so here's a thread on what it actually says. 🧵
                      https://phmpt.org/wp-content/uploads...nce.pdf…9:49 PM · Mar 1, 2022

                      This document describes the post-marketing data of the Pfizer vaccine voluntarily (spontaneously) reported to Pfizer as of February 29, 2021, at which point MILLIONS of people had been vaccinated. The US alone was averaging 2 million doses of vaccine per day at that point.

                      We need to get some definitions out of the way or we won't get anywhere (this is dry- sorry). I'll limit this to important ones from the abbreviations.

                      Adverse events (AEs) do not mean what you (probably) think they do. AEs ≠ side effects.


                      AEs are monitored regardless of whether you get the active agent or the placebo in a trial, and that information may be reported in e.g. package inserts. E.g. Gardasil has a report on its package insert of gunshot wounds as an AE. Need I explain that it doesn't cause them?

                      In many clinical trial designs, there is blinding, so you don't know in advance whether or not you get placebo or active agent so you monitor everyone. Additionally, the placebo group helps you to see what is normal for similar people at similar times in similar places.

                      Formally, what most people think of as a side effect is more properly described as an adverse drug reaction (ADR), and for formal purposes the term "side effect" is best avoided altogether:
                      https://ema.europa.eu/en/documents/s...e_en-15.pdf…

                      However, it can be very hard to tease apart what is AE vs. ADR.

                      AEs can be classified as serious or non-serious. These also have very specific definitions. There is also the term "life-threatening adverse event" which has a very specific meaning.

                      "AE of special interest" is a term that appears here (commonly abbreviated AESI). These are literally just adverse events that it's just especially important to track or monitor. That could be because they're serious, because of something about how the drug works...

                      or how related drugs work, or because of how significant it is as a problem. If an AESI occurs, the sponsor (the pharmaceutical company paying for the trial) generally needs to be alerted of it rapidly. https://cioms.ch/wp-content/uploads/2017/01/Mgment_Safety_Info.pdf

                      AESIs get specified in protocols, generally before the trial has even begun, although protocols can be amended to include new AESIs as data emerges. In other words, that big scary list in Appendix 1 that people are claiming are side effects of the Pfizer vaccine? Blatant lie. (My bolding here. s.s.)

                      That list alone tells us nothing about whether or not any of those things happened to anyone in the dataset. They are just things Pfizer wrote in the protocol to be watched for as AESIs. Now, onto the data:

                      Because this information is reported spontaneously (voluntarily), we don't have knowledge of denominators (the same issue as VAERS: https://deplatformdisease.com/blog/an-overview-of-us-vaccine-pharmacovigilance?rq=VAERS…) and so the uses and limitations of these data are similar to VAERS's.

                      In other words the main value of this data is if it identifies a significant spike in a particular AE, you can do a more granular analysis in a more rigorous pharmacovigilance system like the VSD. So, what did it find?

                      Table 2 discusses AEs found in more than 2% of individuals. I couldn't find a serious one; most describe reactogenicity symptoms- things that indicate that the immune system is generating a response to the vaccine. They are unpleasant, but temporary and are not a safety concern.

                      Much of the information in this document is now redundant or irrelevant because of real-world data. Table 4 discusses the detailed findings for anaphylaxis but doesn't allow us to estimate a rate. Today that rate looks to be somewhere around 1 per 200,000 vaccine doses.

                      Table 5 has to do with important potential risks, e.g. VAERD (vaccine-associated enhanced respiratory disease) where COVID-19 becomes more severe in vaccinated people. This has not been observed and there is significant evidence to the contrary e.g.

                      Table 6 is about missing information e.g. use of the vaccine in pregnant individuals or in children. This is outdated- we now know quite clearly that vaccination for both groups is safe and essential. The vaccine can also be given without interrupting breastfeeding.

                      Table 7 is the big scary table going through the AESIs captured by spontaneous reporting. None generated a signal, meaning they do not occur appreciably more frequently than the background rate in this dataset. While they may be underreported, this is less likely for serious AEs.

                      There is then a section on medication errors. 7 deaths were reported but the footnote explains that there is no clear link between the vaccination and the death in these cases. Watch millions of people for a few months and a bunch of them will die. Some things are coincidence.

                      Table 8 goes into the details. Anyway, what does this report actually tell us? There was no clear indication of any kind of substantial safety problem with the Pfizer/BioNTech COVID-19 vaccine as of February 29, 2021. Let's stop misrepresenting these documents henceforth.

                      I will add that this document did not identify a signal for myocarditis (though it was an AESI); this is likely related to the fact that the condition is mainly limited to younger males and few had been receiving the vaccine at the point the analysis was done.

                      Also my b- it's supposed to be through February 28, 2021 (there is no February 29, 2021; I misread the dates).

                      Edward Nirenberg 🇺🇦@ENirenberg·6hReplying to @ENirenberg
                      Going to add this- I didn’t bother with a rigorous estimate of how many doses were given but this is a good way to put things into perspective:Quote

                      TweetJames 💙 Neill - 😷 🇪🇺🇮🇪🇬🇧🔶@jneill · 9hReplying to @ENirenberg
                      Also a hot (incorrect) take is 1,223 fatal from 42,086 cases...
                      But denominator should be number of doses, not number of reports. Doses were redacted from the document but are estimated at 119 million.
                      And of course most fatalities are only temporally connected, not causatively

                      -------------------------------------------------------------------------------------------------------

                      I have no idea from where Nirenberg receives $.


                      "Nirenberg majored in biochemistry at Cornell University, earning a bachelor of science degree in 2019. He also took immunology courses, worked as a lab research assistant, and learned about the anti-vaccine culture that has often challenged public health.

                      After graduating, he worked briefly as a medical scribe for a urology office and emergency department in New York City. But when COVID forced shutdowns, Nirenberg lost his job. He began blogging in November 2020, and a month later, he said he already had a following."

                      snip

                      "Earlier this year, Risa Hoshino, MD, a New York City pediatrician, started reading his work and contacted him.

                      "He knows what he's talking about," Hoshino told MedPage Today. He also has the "unique ability" to communicate scientific topics well to both science and lay audiences, she added.

                      Hoshino vetted him, she said, just as she vets any potential collaborator. Not only is he passionate, but "he has original ideas, he writes really well," she noted.

                      They co-authored an opinion piece calling childhood COVID a "crisis" for MedPage Today in mid-June, with Nirenberg listed as the lead author.

                      Both are part of "a grassroots community of vaccination advocates," said collaborator Daniel Freedman, DO, a pediatric neurologist based in Austin, Texas. They teamed with a few others to write a column about vaccination in kids for a BMJ blog, which was published online later in June.

                      Nirenberg was identified as "a science communicator and vaccine advocate" by the journal. He wrote an equal portion of the piece, Freedman said.

                      "I think he is a very strong science communicator, he has a very, very good understanding of basic science," Freedman added."

                      more...

                      https://www.medpagetoday.com/special...clusives/96262

                      Comment


                      • GardenSpider
                        GardenSpider commented
                        Editing a comment
                        Interesting. Thank you for posting this explanation. There may be others.
                        It seemed likely to be their list of adverse reactions given their use of fraudulent data sets that obscured vaccine injuries and deaths related to the vaccine.

                      • GardenSpider
                        GardenSpider commented
                        Editing a comment
                        Interestingly, I found this interview with mathematician Philip Tomlinson who lectured in data organization and control.
                        I don't think it can be determined that the Pfizer data supports their claim the vaccines are safe. He says the data doesn't stack up.
                        See his explanation that raises serious questions.
                        COUNTERSPIN - A Timaru, New Zealand, based 80 year old mathematician tells of his findings into Pfizer data that was legally forced to be released which included 600 deaths within 24 hours along with a host of other inconsistencies. In his working life, Philip has moved in close to a dozen different academic directions. His journey has embraced successful lawcourt work in as an expert in mathematics and computer technology. In this video his past work lecturing in data organisation and control opens up what we could call Pfizer's previously tightly drawn dark curtains.

                      • GardenSpider
                        GardenSpider commented
                        Editing a comment
                        Dr. Edward Nirenberg is a 20s something medical blogger who graduated from the school of agriculture and life sciences. He is a young social media influencer who uses these platforms to "bust myths" that promote vaccine hesitancy. He is pro-vaccine and clearly doesn't have any understanding of how they could be, and are dangerous. He says, "I have a bigger audience now (still don’t get how that happened) than I’m used to so I need to clarify some things about me. Firstly, I am not a public health expert, nor an expert on COVID-19, pandemics generally, virology, infectious disease, or medicine.— Edward Nirenberg (@ENirenberg) December 20, 2020

                        Everything that I have found online confirms the position that the Pfizer data shows the shot to be dangerous to human health.
                        Edward has oversimplified the explanations, when no such inferences can be made given the data points. Many skilled knowledgable, and experienced professionals are pouring over the Pfizer data and what they have to say is damning to say the least.


                    • Click image for larger version  Name:	Screen-Shot-2022-01-03-at-2.02.42-AM-1536x828.png Views:	2 Size:	226.1 KB ID:	941585
                      From the Canadian CoVid Care Alliance.

                      PFIZER DATA PROVES THEIR INOCULATIONS DO MORE HARM THAN GOOD
                      https://www.canadiancovidcareallianc...ec-16-2021.pdf

                      See the video here that goes over the material from the trials.
                      https://rumble.com/vqx3kb-the-pfizer...than-good.html

                      The material describes how the process of the phase studies of the vaccine was abridged in 2 months not the 3-years the study was designed for, with the study blinds removed and candidates on placebo being allowed to switch to the vaccine group too soon for scientific study reliability. This means that “for the rest of the trial there was no way to access efficacy or safety.”

                      The thought-provoking documentary further explains that when Pfizer announced 95% efficacy of its vaccine, this claim was based on “relative risk” and not “absolute risk,” the more useful scientific term. Claiming Pfizer misled the public, the document explains that overall the Pfizer vaccine was able to reduce the risk of covid disease from a fraction of 0.84% (without vaccine use) to 0.04% (with vaccine use), the difference being the relative risk 95% advantage.

                      In the trial, 8 out of 18,198 given vaccine developed covid-19, that’s 0.04%, vs 162 in placebo group or 0.88%. The difference of 0.84% being pushed to the public as the 0.84% gain or 95% efficacy.

                      ‘The number does not mean the vaccine protects you 95% of the time. The FDA recommends using absolute risk.’

                      The group explained that the public was more interested in the absolute risk reduction and benefit of the shots, which would be a mere 0.84%. This considered with the many side-effect reported risks of the vaccine by itself paints a picture of a high risk, low benefit intervention not reflected in the 95% efficacy advertisement.

                      “There is no benefit to a reduction in cases if it comes at the cost of increased sickness and death”

                      ‘The inoculated arm showed an increase in adverse events in almost every category, eg, there were almost 5000 in the experimental arm and just over 1000 in the placebo arm.'

                      Comment

                      Working...
                      X